XRAY icon

Dentsply Sirona

14.40 USD
-0.26
1.77%
At close Aug 25, 4:00 PM EDT
Pre-market
14.32
-0.08
0.56%
1 day
-1.77%
5 days
3.08%
1 month
-10.17%
3 months
-11.87%
6 months
-23.49%
Year to date
-23.20%
1 year
-43.04%
5 years
-67.04%
10 years
-71.80%
 

About: Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

Employees: 14,000

0
Funds holding %
of 7,428 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

148% more call options, than puts

Call options by funds: $4.65M | Put options by funds: $1.88M

82% more repeat investments, than reductions

Existing positions increased: 166 | Existing positions reduced: 91

71% more first-time investments, than exits

New positions opened: 84 | Existing positions closed: 49

25% more funds holding in top 10

Funds holding in top 10: 4 [Q1] → 5 (+1) [Q2]

8% more funds holding

Funds holding: 355 [Q1] → 383 (+28) [Q2]

7% more capital invested

Capital invested by funds: $2.96B [Q1] → $3.16B (+$207M) [Q2]

0.45% more ownership

Funds ownership: 99.45% [Q1] → 99.9% (+0.45%) [Q2]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$15
4%
upside
Avg. target
$18.50
28%
upside
High target
$24
67%
upside

4 analyst ratings

positive
50%
neutral
50%
negative
0%
UBS
Kevin Caliendo
67%upside
$24
Buy
Maintained
8 Aug 2025
Barrington Research
Michael Petusky
25%upside
$18
Outperform
Maintained
8 Aug 2025
Wells Fargo
Vik Chopra
4%upside
$15
Equal-Weight
Maintained
8 Aug 2025
Stifel
Jonathan Block
18%upside
$17
Hold
Maintained
8 Aug 2025

Financial journalist opinion

Based on 16 articles about XRAY published over the past 30 days

Neutral
Zacks Investment Research
4 days ago
Is the Options Market Predicting a Spike in DENTSPLY Stock?
Investors need to pay close attention to XRAY stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in DENTSPLY Stock?
Positive
Benzinga
6 days ago
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Positive
Seeking Alpha
6 days ago
Dentsply Sirona: Turnaround Potential And Digital Workflows
XRAY's EDS and Wellspect are the key to stabilizing their results going forward. OIS and CTS continue to decline, but SureSmile grows in Europe. Their new CEO will also prioritize execution, rather than reinventing XRAY. They'll double down on integrated digital workflows and better customer experience. If they build a stickier ecosystem, I think XRAY does have the potential for a turnaround.
Dentsply Sirona: Turnaround Potential And Digital Workflows
Neutral
Zacks Investment Research
2 weeks ago
International Markets and Dentsply (XRAY): A Deep Dive for Investors
Explore Dentsply's (XRAY) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
International Markets and Dentsply (XRAY): A Deep Dive for Investors
Positive
Zacks Investment Research
2 weeks ago
Why Dentsply International (XRAY) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Dentsply International (XRAY) is a Top Growth Stock for the Long-Term
Neutral
Seeking Alpha
2 weeks ago
DENTSPLY SIRONA Inc. (XRAY) Q2 2025 Earnings Call Transcript
DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q2 2025 Earnings Call August 7, 2025 8:30 AM ET Company Participants Andrea Daley - Vice President of Investor Relations Daniel T. Scavilla - President, CEO & Director Matthew E.
DENTSPLY SIRONA Inc. (XRAY) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
2 weeks ago
XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up
DENTSPLY SIRONA tops Q2 earnings estimates with margin gains, but revenue declines and U.S. weakness persists.
XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up
Neutral
The Motley Fool
2 weeks ago
Dentsply Sirona (XRAY) Q2 Sales Drop 5%
Dentsply Sirona (XRAY) Q2 Sales Drop 5%
Dentsply Sirona (XRAY) Q2 Sales Drop 5%
Positive
Zacks Investment Research
2 weeks ago
Dentsply (XRAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Dentsply (XRAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Positive
Zacks Investment Research
2 weeks ago
Dentsply International (XRAY) Tops Q2 Earnings and Revenue Estimates
Dentsply International (XRAY) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.49 per share a year ago.
Dentsply International (XRAY) Tops Q2 Earnings and Revenue Estimates
Charts implemented using Lightweight Charts™